332 HA Lee, et al 25. Chen J, Zheng R, Melman YF, McDonald TV. Functional interactions between KCNE1 C-terminus and the KCNQ1 channel. PLoS One. 2009;4:e5143. 26. Li GR, Lau CP, Ducharme A, Tardif JC, Nattel S. Transmural action potential and ionic current remodeling in ventricles of failingcanine hearts. Am J Physiol Heart Circ Physiol. 2002; 283:H1031-1041. 27. Jiang M, Zhang M, Tang DG, Clemo HF, Liu J, Holwitt D, Kasirajan V, Pond AL, Wettwer E, Tseng GN. KCNE2 protein is expressed in ventricles of different species, and changes in its expression contribute to electrical remodeling in diseased hearts. Circulation. 2004;109:1783-1788. 28. Näbauer M, Kääb S. Potassium channel down-regulation in heart failure. Cardiovasc Res. 1998;37:324-334. 29. Tsuboi M, Antzelevitch C. Cellular basis for electrocardiogra- phic and arrhythmic manifestations of Andersen-Tawil synd- rome (LQT7). Heart Rhythm. 2006;3:328-335. 30. Grant AO, Carboni MP, Neplioueva V, Starmer CF, Memmi M, Napolitano C, Priori S. Long QT syndrome, Brugada syndrome, and conduction system disease are linked to a single sodium channel mutation. J Clin Invest. 2002;110:1201-1209. 31. Splawski I, Timothy KW, Decher N, Kumar P, Sachse FB, Beggs AH, Sanguinetti MC, Keating MT. Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc Natl Acad Sci USA. 2005;102:8089-8096. 32. Pacher P, Ungvari Z, Nanasi PP, Furst S, Kecskemeti V. Speculations on difference between tricyclic and selective serotonin reuptake inhibitor antidepressants on their cardiac effects. Is there any? Curr Med Chem. 1999;6:469-480. 33. De Ponti F, Poluzzi E, Cavalli A, Recanatini M, Montanaro N. Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview. Drug Saf. 2002;25:263-286. 34. Haddad PM, Anderson IM. Antipsychotic-related QTc prolon- gation, torsade de pointes and sudden death. Drugs. 2002;62: 1649-1671. 35. Witchel HJ, Hancox JC, Nutt DJ. Psychotropic drugs, cardiac arrhythmia, and sudden death. J Clin Psychopharmacol. 2003; 23:58-77. 36. Pousti A, Bakhtiarian A, Najafi R, Deemyad T, Brumand K, Hosseini MJ. Effect of sertraline on ouabain-induced arrhyth- mia in isolated guinea-pig atria. Depress Anxiety. 2009;26: E106-110. 37. Amin M, Lehmann H, Mirmiran J. A double-blind, placebo- controlled dose-finding study with sertraline. Psychopharmacol Bull. 198925:164-167. 38. de Boer RA, van Dijk TH, Holman ND, van Melle JP. QT interval prolongation after sertraline overdose: a case report. BMC Emerg Med. 2005;5:5. 39. Kocabay G, Yildiz M, Eksi Duran N, Ozkan M. Sinus arrest due to sertraline. Clin Cardiol. 2010;33:E114-115. 40. Patel NH, Golwala H, Stavrakis S, Schechter E. Sertraline- Induced Ventricular Tachycardia. Am J Ther. 2011. [Epub ahead of print]